- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05050084
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
Study Overview
Status
Conditions
Detailed Description
PRIMARY OBJECTIVES:
I. To determine whether men with National Comprehensive Cancer Network (NCCN) unfavorable intermediate risk (UIR) prostate cancer and lower Decipher genomic risk (Decipher score < 0.40) treated with radiation therapy (RT) alone instead of 6 months androgen deprivation therapy (ADT) + RT experience non-inferior rate of distant metastasis. (De-intensification study) II. To determine whether men with NCCN UIR prostate cancer who are in the higher genomic risk (Decipher score >= 0.40) will have a superior metastasis-free survival through treatment intensification with darolutamide added to the standard of RT plus 6 months ADT. (Intensification study)
SECONDARY OBJECTIVES:
I. To compare overall survival (OS) between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
II. To compare time to prostate specific antigen (PSA) failure between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
III. To compare metastasis free survival (MFS) based on conventional imaging between the standard of care (RT plus 6 months of ADT) and de-intensification intervention (RT alone).
IV. To compare MFS based on either conventional and/or molecular imaging between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
V. To compare cumulative incidence of locoregional failure based upon conventional imaging and/ or biopsy between standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months ADT plus darolutamide) interventions.
VI. To compare cumulative incidence of distant metastasis based upon conventional imaging between standard of care (RT plus 6 months of ADT) and intensification intervention (RT plus 6 months ADT plus darolutamide).
VII. To compare cumulative incidence of distant metastasis based upon either conventional and/or molecular imaging between standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
VIII. To compare prostate cancer-specific mortality between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
IX. To compare sexual and hormonal related quality of life, as measured by the Expanded Prostate Cancer Index Composite-26 (EPIC), between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
X. To compare fatigue, as measured by the Patient Reported Outcomes Measurement Information System (PROMIS)-Fatigue instrument, between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
XI. To compare cognition, as measured by the Functional Assessment of Chronic Illness Therapy-Cognitive (FACT-Cog) perceived cognitive abilities subscale, between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
EXPLORATORY OBJECTIVES:
I. To compare changes in cardio-metabolic markers, including body mass index, lipids, blood glucose, complete blood count (CBC), comprehensive metabolic panel (CMP), and hemoglobin (Hgb) A1c, between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
II. To compare PSA failure-free survival with non-castrate testosterone and no additional therapies between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
III. To compare cumulative incidence of locoregional failure based upon either conventional and/or molecular imaging between standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
IV. To compare castrate-resistant prostate cancer (CRPC) between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
V. To compare bowel and urinary function related quality of life, as measured by the Expanded Prostate Cancer Index Composite-26 (EPIC), between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
VI. To compare time to testosterone recovery (defined as a T > 200ng/dL) between the standard of care (RT plus 6 months of ADT) and intensification (RT plus 6 months of ADT plus darolutamide) interventions.
VII. To compare health utilities, as measured by the European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L), between the standard of care (RT plus 6 months of ADT) and either the de-intensification (RT alone) or intensification (RT plus 6 months of ADT plus darolutamide) interventions.
VIII. To develop and assess a machine learning/artificial intelligence algorithm for radiotherapy planning and/or quality assurance.
IX. To perform future translational correlative studies using biological data, Decipher results, and clinical outcomes.
OUTLINE:
DE-INTENSIFICATION STUDY: Patients with Decipher score < 0.40 are randomized to 1 of 2 arms.
ARM I: Patients undergo radiation therapy (RT) using a recognized regimen (2-3 days a week or 5 days a week for 2-11 weeks) in the absence of disease progression or unacceptable toxicity.
ARM II: Patients undergo RT as Arm I. Patients also receive androgen deprivation therapy (ADT) consisting of leuprolide, goserelin, buserelin, histrelin, triptorelin, degarelix, or relugolix at the discretion of the treating physician, for 6 months in the absence of disease progression or unacceptable toxicity. Patients may also receive bicalutamide or flutamide for 0, 30 or 180 days.
INTENSIFICATION STUDY: Patients with Decipher score >= 0.40 are randomized to 1 of 2 arms.
ARM III: Patients receive treatment as in Arm II.
ARM IV: Patients receive RT and ADT as in Arm II. Patients also receive darolutamide orally (PO) twice daily (BID). Treatment repeats every 90 days for up to 2 cycles in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up at 3, 6, 12, 24, 36, 48 and 60 months.
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 5G2
- Arthur J E Child Comprehensive Cancer Centre
-
-
New Brunswick
-
Saint John, New Brunswick, Canada, E2L 4L2
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
-
-
Ontario
-
Hamilton, Ontario, Canada, L8V 5C2
- Juravinski Cancer Centre at Hamilton Health Sciences
-
Toronto, Ontario, Canada, M5G 2M9
- University Health Network-Princess Margaret Hospital
-
-
Quebec
-
Montreal, Quebec, Canada, H3H 2R9
- The Research Institute of the McGill University Health Centre (MUHC)
-
Québec, Quebec, Canada, G1R 2J6
- CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada, S4T 7T1
- Allan Blair Cancer Centre
-
Saskatoon, Saskatchewan, Canada, S7N 4H4
- Saskatoon Cancer Centre
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Arizona
-
Gilbert, Arizona, United States, 85234
- Banner MD Anderson Cancer Center
-
Gilbert, Arizona, United States, 85297
- Arizona Center for Cancer Care - Gilbert
-
Peoria, Arizona, United States, 85381
- Arizona Center for Cancer Care-Peoria
-
Phoenix, Arizona, United States, 85027
- Arizona Center for Cancer Care - Phoenix
-
Scottsdale, Arizona, United States, 85258
- Arizona Center for Cancer Care - Scottsdale
-
Surprise, Arizona, United States, 85374
- Arizona Center for Cancer Care-Surprise
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Auburn, California, United States, 95603
- Sutter Cancer Centers Radiation Oncology Services-Auburn
-
Bakersfield, California, United States, 93301
- AIS Cancer Center at San Joaquin Community Hospital
-
Beverly Hills, California, United States, 90211
- Tower Cancer Research Foundation
-
Cameron Park, California, United States, 95682
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
-
Corona, California, United States, 92882
- City of Hope Corona
-
Duarte, California, United States, 91010
- City of Hope Comprehensive Cancer Center
-
Dublin, California, United States, 94568
- Kaiser Permanente Dublin
-
Encinitas, California, United States, 92024
- UC San Diego Health System - Encinitas
-
Fremont, California, United States, 94538
- Kaiser Permanente-Fremont
-
Fremont, California, United States, 94538
- Washington Hospital
-
Fresno, California, United States, 93720
- Kaiser Permanente-Fresno
-
Fresno, California, United States, 93720
- Kaiser Permanente Fresno Orchard Plaza
-
Greenbrae, California, United States, 94904
- Marin General Hospital
-
Irvine, California, United States, 92618
- City of Hope at Irvine Lennar
-
Irvine, California, United States, 92612
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
-
La Jolla, California, United States, 92093
- UC San Diego Moores Cancer Center
-
Lancaster, California, United States, 93534
- City of Hope Antelope Valley
-
Los Angeles, California, United States, 90033
- USC / Norris Comprehensive Cancer Center
-
Los Angeles, California, United States, 90048
- Cedars Sinai Medical Center
-
Los Angeles, California, United States, 90033
- Los Angeles General Medical Center
-
Marysville, California, United States, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, United States, 95355
- Memorial Medical Center
-
Modesto, California, United States, 95356
- Kaiser Permanente-Modesto
-
Modesto, California, United States, 95356
- Kaiser Permanente- Modesto MOB II
-
Napa, California, United States, 94558
- Providence Queen of The Valley
-
Oakland, California, United States, 94611
- Kaiser Permanente-Oakland
-
Orange, California, United States, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Orange, California, United States, 92868
- Saint Joseph Hospital - Orange
-
Palo Alto, California, United States, 94301
- Palo Alto Medical Foundation Health Care
-
Roseville, California, United States, 95661
- Kaiser Permanente-Roseville
-
Roseville, California, United States, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Sacramento, California, United States, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, United States, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, United States, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, United States, 95823
- Kaiser Permanente-South Sacramento
-
San Diego, California, United States, 92123
- Sharp Memorial Hospital
-
San Diego, California, United States, 92121
- California Protons Cancer Therapy Center
-
San Francisco, California, United States, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, United States, 94158
- UCSF Medical Center-Mission Bay
-
San Jose, California, United States, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, United States, 94577
- Kaiser Permanente San Leandro
-
Santa Barbara, California, United States, 93105
- Ridley-Tree Cancer Center
-
Santa Clara, California, United States, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, United States, 95403
- Kaiser Permanente-Santa Rosa
-
South Pasadena, California, United States, 91030
- City of Hope South Pasadena
-
South San Francisco, California, United States, 94080
- Kaiser Permanente-South San Francisco
-
Sunnyvale, California, United States, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Tarzana, California, United States, 91356
- Cedars-Sinai Cancer - Tarzana
-
Torrance, California, United States, 90509
- Torrance Memorial Medical Center
-
Torrance, California, United States, 90505
- Torrance Memorial Physician Network - Cancer Care
-
Torrance, California, United States, 90503
- City of Hope South Bay
-
Truckee, California, United States, 96161
- Gene Upshaw Memorial Tahoe Forest Cancer Center
-
Upland, California, United States, 91786
- City of Hope Upland
-
Vallejo, California, United States, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, United States, 94589
- Sutter Solano Medical Center/Cancer Center
-
Walnut Creek, California, United States, 94596
- Kaiser Permanente-Walnut Creek
-
Walnut Creek, California, United States, 94598
- BASS Medical Group - Lennon
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- UCHealth University of Colorado Hospital
-
Boulder, Colorado, United States, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Colorado Springs, Colorado, United States, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, United States, 80920
- Memorial Hospital North
-
Edwards, Colorado, United States, 81632
- Shaw Cancer Center
-
Fort Collins, Colorado, United States, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, United States, 80528
- Cancer Care and Hematology-Fort Collins
-
Greeley, Colorado, United States, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, United States, 80631
- Banner North Colorado Medical Center
-
Highlands Ranch, Colorado, United States, 80129
- UCHealth Highlands Ranch Hospital
-
Loveland, Colorado, United States, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, United States, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
-
Connecticut
-
Bridgeport, Connecticut, United States, 06606
- Hartford HealthCare - Saint Vincent's Medical Center
-
Danbury, Connecticut, United States, 06810
- Danbury Hospital
-
Greenwich, Connecticut, United States, 06830
- Smilow Cancer Hospital Care Center at Greenwich
-
Guilford, Connecticut, United States, 06437
- Smilow Cancer Hospital Care Center - Guilford
-
Hartford, Connecticut, United States, 06102
- Hartford Hospital
-
Meriden, Connecticut, United States, 06451
- Midstate Medical Center
-
New Britain, Connecticut, United States, 06050
- The Hospital of Central Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale University
-
Norwalk, Connecticut, United States, 06856
- Norwalk Hospital
-
Trumbull, Connecticut, United States, 06611
- Smilow Cancer Hospital Care Center-Trumbull
-
Waterford, Connecticut, United States, 06385
- Smilow Cancer Hospital Care Center - Waterford
-
-
Delaware
-
Millville, Delaware, United States, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, United States, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, United States, 19713
- Medical Oncology Hematology Consultants PA
-
Rehoboth Beach, Delaware, United States, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20037
- George Washington University Medical Center
-
-
Florida
-
Bay Pines, Florida, United States, 33744
- Bay Pines VA Healthcare System
-
Boca Raton, Florida, United States, 33486
- Boca Raton Regional Hospital
-
Gainesville, Florida, United States, 32610
- UF Health Cancer Institute - Gainesville
-
Jupiter, Florida, United States, 33458
- Jupiter Medical Center
-
Plantation, Florida, United States, 33324
- GenesisCare USA - Plantation
-
Weston, Florida, United States, 33331
- Cleveland Clinic-Weston
-
-
Georgia
-
Atlanta, Georgia, United States, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, United States, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, United States, 30342
- Emory Saint Joseph's Hospital
-
Atlanta, Georgia, United States, 30303
- Grady Health System
-
Atlanta, Georgia, United States, 30309
- Piedmont Hospital
-
Atlanta, Georgia, United States, 30308
- Emory Proton Therapy Center
-
Decatur, Georgia, United States, 30033
- Emory Decatur Hospital
-
Fayetteville, Georgia, United States, 30214
- Piedmont Fayette Hospital
-
Gainesville, Georgia, United States, 30501
- Northeast Georgia Medical Center-Gainesville
-
Johns Creek, Georgia, United States, 30097
- Emory Johns Creek Hospital
-
Savannah, Georgia, United States, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, United States, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, United States, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, United States, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, United States, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, United States, 96817
- Queen's Cancer Center - Kuakini
-
‘Aiea, Hawaii, United States, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, United States, 96701
- Pali Momi Medical Center
-
‘Ewa Beach, Hawaii, United States, 96706
- The Queen's Medical Center - West Oahu
-
-
Idaho
-
Boise, Idaho, United States, 83712
- Saint Luke's Cancer Institute - Boise
-
Fruitland, Idaho, United States, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, United States, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, United States, 83687
- Saint Luke's Cancer Institute - Nampa
-
Twin Falls, Idaho, United States, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Alton, Illinois, United States, 62002
- Alton Memorial Hospital
-
Aurora, Illinois, United States, 60504
- Rush-Copley Medical Center
-
Barrington, Illinois, United States, 60010
- Advocate Good Shepherd Hospital
-
Bloomington, Illinois, United States, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, United States, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, United States, 62321
- Illinois CancerCare-Carthage
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
Chicago, Illinois, United States, 60612
- University of Illinois
-
Chicago, Illinois, United States, 60657
- Advocate Illinois Masonic Medical Center
-
Chicago, Illinois, United States, 60612
- Rush MD Anderson Cancer Center
-
Crystal Lake, Illinois, United States, 60014
- AMG Crystal Lake - Oncology
-
Danville, Illinois, United States, 61832
- Carle at The Riverfront
-
DeKalb, Illinois, United States, 60115
- Northwestern Medicine Cancer Center Kishwaukee
-
Decatur, Illinois, United States, 62526
- Decatur Memorial Hospital
-
Downers Grove, Illinois, United States, 60515
- Advocate Good Samaritan Hospital
-
Effingham, Illinois, United States, 62401
- Crossroads Cancer Center
-
Elgin, Illinois, United States, 60123
- Advocate Sherman Hospital
-
Elmhurst, Illinois, United States, 60126
- Elmhurst Memorial Hospital
-
Eureka, Illinois, United States, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, United States, 61401
- Illinois CancerCare-Galesburg
-
Geneva, Illinois, United States, 60134
- Northwestern Medicine Cancer Center Delnor
-
Glenview, Illinois, United States, 60026
- Northwestern Medicine Glenview Outpatient Center
-
Grayslake, Illinois, United States, 60030
- Northwestern Medicine Grayslake Outpatient Center
-
Hazel Crest, Illinois, United States, 60429
- Advocate South Suburban Hospital
-
Hines, Illinois, United States, 60141
- Edward Hines Jr VA Hospital
-
Kewanee, Illinois, United States, 61443
- Illinois CancerCare-Kewanee Clinic
-
Lake Forest, Illinois, United States, 60045
- Northwestern Medicine Lake Forest Hospital
-
Libertyville, Illinois, United States, 60048
- Condell Memorial Hospital
-
Libertyville, Illinois, United States, 60048
- AMG Libertyville - Oncology
-
Macomb, Illinois, United States, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, United States, 61938
- Carle Physician Group-Mattoon/Charleston
-
Maywood, Illinois, United States, 60153
- Loyola University Medical Center
-
Naperville, Illinois, United States, 60540
- Edward Hospital/Cancer Center
-
O'Fallon, Illinois, United States, 62269
- HSHS Saint Elizabeth's Hospital
-
Oak Brook, Illinois, United States, 60523
- Northwestern Medicine Oak Brook
-
Oak Lawn, Illinois, United States, 60453-2699
- Advocate Christ Medical Center
-
Orland Park, Illinois, United States, 60462
- Northwestern Medicine Orland Park
-
Ottawa, Illinois, United States, 61350
- Illinois CancerCare-Ottawa Clinic
-
Palos Heights, Illinois, United States, 60463
- Advocate High Tech Medical Park
-
Park Ridge, Illinois, United States, 60068
- Advocate Lutheran General Hospital
-
Pekin, Illinois, United States, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, United States, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, United States, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, United States, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, United States, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, United States, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, United States, 61114
- UW Health Carbone Cancer Center Rockford
-
Shiloh, Illinois, United States, 62269
- Memorial Hospital East
-
Springfield, Illinois, United States, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, United States, 61801
- Carle Cancer Center
-
Warrenville, Illinois, United States, 60555
- Northwestern Medicine Cancer Center Warrenville
-
Washington, Illinois, United States, 61571
- Illinois CancerCare - Washington
-
-
Iowa
-
Cedar Rapids, Iowa, United States, 52403
- Mercy Hospital
-
Cedar Rapids, Iowa, United States, 52402
- Saint Luke's Hospital
-
Des Moines, Iowa, United States, 50309
- Iowa Methodist Medical Center
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University of Kansas Cancer Center
-
Olathe, Kansas, United States, 66061
- The University of Kansas Cancer Center - Olathe
-
Overland Park, Kansas, United States, 66210
- University of Kansas Cancer Center-Overland Park
-
Overland Park, Kansas, United States, 66211
- University of Kansas Hospital-Indian Creek Campus
-
Salina, Kansas, United States, 67401
- Salina Regional Health Center
-
Topeka, Kansas, United States, 66606
- University of Kansas Health System Saint Francis Campus
-
Topeka, Kansas, United States, 66606
- Cotton O'Neil Cancer Center / Stormont Vail Health
-
Westwood, Kansas, United States, 66205
- University of Kansas Hospital-Westwood Cancer Center
-
Wichita, Kansas, United States, 67214
- Ascension Via Christi Hospitals Wichita
-
-
Kentucky
-
Lexington, Kentucky, United States, 40504
- Saint Joseph Radiation Oncology Resource Center
-
-
Louisiana
-
Metairie, Louisiana, United States, 70006
- East Jefferson General Hospital
-
Metairie, Louisiana, United States, 70006
- LSU Healthcare Network / Metairie Multi-Specialty Clinic
-
Metairie, Louisiana, United States, 70002
- Mary Bird Perkins Cancer Center - Metairie
-
-
Maine
-
Portland, Maine, United States, 04102
- MaineHealth Maine Medical Center - Portland
-
Rockport, Maine, United States, 04856
- Penobscot Bay Medical Center
-
Scarborough, Maine, United States, 04074
- MaineHealth Maine Medical Center- Scarborough
-
South Portland, Maine, United States, 04106
- MaineHealth Cancer Care and IV Therapy - South Portland
-
-
Maryland
-
Annapolis, Maryland, United States, 21401
- Luminis Health Anne Arundel Medical Center
-
Baltimore, Maryland, United States, 21201
- University of Maryland/Greenebaum Cancer Center
-
Baltimore, Maryland, United States, 21201
- Maryland Proton Treatment Center
-
Bel Air, Maryland, United States, 21014
- UM Upper Chesapeake Medical Center
-
Columbia, Maryland, United States, 21044
- Central Maryland Radiation Oncology in Howard County
-
Easton, Maryland, United States, 21601
- University of Maryland Shore Medical Center at Easton
-
Glen Burnie, Maryland, United States, 21061
- UM Baltimore Washington Medical Center/Tate Cancer Center
-
Largo, Maryland, United States, 20774
- UM Capital Region Medical Center
-
Ocean Pines, Maryland, United States, 21811
- TidalHealth Richard A Henson Cancer Institute
-
Salisbury, Maryland, United States, 21801
- TidalHealth Peninsula Regional
-
-
Massachusetts
-
Beverly, Massachusetts, United States, 01915
- Beverly Hospital
-
Burlington, Massachusetts, United States, 01805
- Lahey Hospital and Medical Center
-
Gloucester, Massachusetts, United States, 01930
- Addison Gilbert Hospital
-
Peabody, Massachusetts, United States, 01960
- Lahey Medical Center-Peabody
-
Winchester, Massachusetts, United States, 01890
- Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Rogel Cancer Center
-
Ann Arbor, Michigan, United States, 48105
- Veteran's Administration Medical Center - Ann Arbor
-
Ann Arbor, Michigan, United States, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Bay City, Michigan, United States, 48706
- McLaren Cancer Institute-Bay City
-
Brighton, Michigan, United States, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, United States, 48114
- Trinity Health Medical Center - Brighton
-
Brownstown, Michigan, United States, 48183
- Henry Ford Cancer Institute-Downriver
-
Canton, Michigan, United States, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, United States, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, United States, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, United States, 48118
- Chelsea Hospital
-
Clarkston, Michigan, United States, 48346
- McLaren Cancer Institute-Clarkston
-
Clarkston, Michigan, United States, 48346
- Michigan Healthcare Professionals Clarkston
-
Clinton Township, Michigan, United States, 48038
- Henry Ford Macomb Hospital-Clinton Township
-
Detroit, Michigan, United States, 48202
- Henry Ford Hospital
-
Detroit, Michigan, United States, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, United States, 48334
- Weisberg Cancer Treatment Center
-
Farmington Hills, Michigan, United States, 48334
- Michigan Healthcare Professionals Farmington
-
Flint, Michigan, United States, 48532
- McLaren Cancer Institute-Flint
-
Flint, Michigan, United States, 48503
- Genesys Hurley Cancer Institute
-
Grand Rapids, Michigan, United States, 49503
- Trinity Health Grand Rapids Hospital
-
Kalamazoo, Michigan, United States, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, United States, 49007
- Bronson Methodist Hospital
-
Lansing, Michigan, United States, 48910
- Karmanos Cancer Institute at McLaren Greater Lansing
-
Lansing, Michigan, United States, 48912
- University of Michigan Health - Sparrow Lansing
-
Lapeer, Michigan, United States, 48446
- McLaren Cancer Institute-Lapeer Region
-
Livonia, Michigan, United States, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Macomb, Michigan, United States, 48044
- Michigan Healthcare Professionals Macomb
-
Madison Heights, Michigan, United States, 48071
- Michigan Healthcare Professionals Madison Heights
-
Mount Clemens, Michigan, United States, 48043
- McLaren Cancer Institute-Macomb
-
Mount Pleasant, Michigan, United States, 48858
- McLaren Cancer Institute-Central Michigan
-
Niles, Michigan, United States, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Novi, Michigan, United States, 48377
- Henry Ford Medical Center-Columbus
-
Petoskey, Michigan, United States, 49770
- McLaren Cancer Institute-Northern Michigan
-
Pontiac, Michigan, United States, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Port Huron, Michigan, United States, 48060
- McLaren-Port Huron
-
Royal Oak, Michigan, United States, 48073
- Corewell Health William Beaumont University Hospital
-
Saginaw, Michigan, United States, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, United States, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, United States, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Tawas City, Michigan, United States, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, United States, 49684
- Munson Medical Center
-
Troy, Michigan, United States, 48098
- Michigan Healthcare Professionals Troy
-
Troy, Michigan, United States, 48085
- Corewell Health Beaumont Troy Hospital
-
West Bloomfield, Michigan, United States, 48322
- Henry Ford West Bloomfield Hospital
-
Wyoming, Michigan, United States, 49519
- University of Michigan Health - West
-
Ypsilanti, Michigan, United States, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Coon Rapids, Minnesota, United States, 55433
- Mercy Hospital
-
Duluth, Minnesota, United States, 55805
- Saint Luke's Hospital of Duluth
-
Duluth, Minnesota, United States, 55805
- Miller-Dwan Hospital
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center
-
Saint Louis Park, Minnesota, United States, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, United States, 55101
- Regions Hospital
-
Stillwater, Minnesota, United States, 55082
- Lakeview Hospital
-
-
Missouri
-
Cape Girardeau, Missouri, United States, 63703
- Saint Francis Medical Center
-
City of Saint Peters, Missouri, United States, 63376
- Siteman Cancer Center at Saint Peters Hospital
-
Columbia, Missouri, United States, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Creve Coeur, Missouri, United States, 63141
- Siteman Cancer Center at West County Hospital
-
Farmington, Missouri, United States, 63640
- Parkland Health Center - Farmington
-
Kansas City, Missouri, United States, 64154
- University of Kansas Cancer Center - North
-
Kansas City, Missouri, United States, 64116
- University of Kansas Cancer Center - Briarcliff
-
Lee's Summit, Missouri, United States, 64064
- University of Kansas Cancer Center - Lee's Summit
-
North Kansas City, Missouri, United States, 64116
- University of Kansas Cancer Center at North Kansas City Hospital
-
Rolla, Missouri, United States, 65401
- Phelps Health Delbert Day Cancer Institute
-
Sainte Genevieve, Missouri, United States, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, United States, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
St Louis, Missouri, United States, 63129
- Siteman Cancer Center-South County
-
St Louis, Missouri, United States, 63136
- Siteman Cancer Center at Christian Hospital
-
St Louis, Missouri, United States, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, United States, 63104
- SSM Health Saint Louis University Hospital
-
Sullivan, Missouri, United States, 63080
- Missouri Baptist Sullivan Hospital
-
Sunset Hills, Missouri, United States, 63127
- BJC Outpatient Center at Sunset Hills
-
-
Montana
-
Billings, Montana, United States, 59101
- Billings Clinic Cancer Center
-
Butte, Montana, United States, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, United States, 59405
- Benefis Sletten Cancer Institute
-
-
Nebraska
-
Bellevue, Nebraska, United States, 68123
- Nebraska Medicine-Bellevue
-
Omaha, Nebraska, United States, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, United States, 68118
- Nebraska Medicine-Village Pointe
-
-
New Hampshire
-
Concord, New Hampshire, United States, 03301
- New Hampshire Oncology Hematology PA-Concord
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Manchester, New Hampshire, United States, 03103
- Solinsky Center for Cancer Care
-
-
New Jersey
-
Basking Ridge, New Jersey, United States, 07920
- Memorial Sloan Kettering Basking Ridge
-
Belleville, New Jersey, United States, 07109
- Clara Maass Medical Center
-
Camden, New Jersey, United States, 08103
- Cooper Hospital University Medical Center
-
Egg Harbor, New Jersey, United States, 08234
- AtlantiCare Surgery Center
-
Elizabeth, New Jersey, United States, 07207
- Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus
-
Englewood, New Jersey, United States, 07631
- Englewood Hospital and Medical Center
-
Hamilton, New Jersey, United States, 08690
- The Cancer Institute of New Jersey Hamilton
-
Jersey City, New Jersey, United States, 07302
- Jersey City Medical Center
-
Livingston, New Jersey, United States, 07039
- Saint Barnabas Medical Center
-
Middletown, New Jersey, United States, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, United States, 07645
- Memorial Sloan Kettering Bergen
-
Mount Laurel, New Jersey, United States, 08054
- Cooper CyberKnife Center
-
New Brunswick, New Jersey, United States, 08903
- Rutgers Cancer Institute of New Jersey
-
Newark, New Jersey, United States, 07101
- Rutgers New Jersey Medical School
-
Newark, New Jersey, United States, 07112
- Newark Beth Israel Medical Center
-
Paramus, New Jersey, United States, 07652
- The Valley Hospital - Luckow Pavilion
-
Sewell, New Jersey, United States, 08080
- Sidney Kimmel Cancer Center Washington Township
-
Somerville, New Jersey, United States, 08876
- Robert Wood Johnson University Hospital Somerset
-
Toms River, New Jersey, United States, 08755
- Community Medical Center
-
Voorhees Township, New Jersey, United States, 08043
- MD Anderson Cancer Center at Cooper-Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87102
- Lovelace Medical Center-Saint Joseph Square
-
Albuquerque, New Mexico, United States, 87109
- Lovelace Radiation Oncology
-
Albuquerque, New Mexico, United States, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, United States, 87110
- Presbyterian Kaseman Hospital
-
Rio Rancho, New Mexico, United States, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Bay Shore, New York, United States, 11706
- Northwell Health Imbert Cancer Center
-
Brooklyn, New York, United States, 11215
- New York-Presbyterian/Brooklyn Methodist Hospital
-
Buffalo, New York, United States, 14263
- Roswell Park Cancer Institute
-
Commack, New York, United States, 11725
- Memorial Sloan Kettering Commack
-
Cooperstown, New York, United States, 13326
- Mary Imogene Bassett Hospital
-
Dansville, New York, United States, 14437
- Noyes Memorial Hospital/Myers Cancer Center
-
East White Plains, New York, United States, 10604
- Memorial Sloan Kettering Westchester
-
Elmira, New York, United States, 14905
- Arnot Ogden Medical Center/Falck Cancer Center
-
Flushing, New York, United States, 11355
- The New York Hospital Medical Center of Queens
-
Forest Hills, New York, United States, 11375
- Northwell Health Physicians Partners Radiation Medicine at Queens
-
Glens Falls, New York, United States, 12801
- Glens Falls Hospital
-
Greenlawn, New York, United States, 11740
- Northwell Health Cancer Institute at Huntington
-
Lake Success, New York, United States, 11042
- Northwell Health/Center for Advanced Medicine
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, United States, 10032
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
-
New York, New York, United States, 10075
- Lenox Hill Hospital
-
New York, New York, United States, 10065
- Manhattan Eye Ear and Throat Hospital
-
Rego Park, New York, United States, 11374
- Queens Cancer Center
-
Rochester, New York, United States, 14642
- University of Rochester
-
Rochester, New York, United States, 14620
- Highland Hospital
-
Sleepy Hollow, New York, United States, 10591
- Phelps Memorial Hospital Center
-
Staten Island, New York, United States, 10305
- Staten Island University Hospital
-
Stony Brook, New York, United States, 11794
- Stony Brook University Medical Center
-
Syracuse, New York, United States, 13210
- State University of New York Upstate Medical University
-
The Bronx, New York, United States, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, United States, 10467
- Montefiore Medical Center - Moses Campus
-
Uniondale, New York, United States, 11553
- Memorial Sloan Kettering Nassau
-
Valhalla, New York, United States, 10595
- Westchester Medical Center
-
Webster, New York, United States, 14580
- Wilmot Cancer Institute at Webster
-
-
North Carolina
-
Asheville, North Carolina, United States, 28801
- Mission Hospital
-
Cary, North Carolina, United States, 27518
- Duke Cancer Center Cary
-
Chapel Hill, North Carolina, United States, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
Durham, North Carolina, United States, 27705
- Durham VA Medical Center
-
Raleigh, North Carolina, United States, 27609
- Duke Cancer Center Raleigh
-
Raleigh, North Carolina, United States, 27607
- UNC Health Cancer Care Raleigh
-
Raleigh, North Carolina, United States, 27614
- UNC Health Cancer Care Wakefield
-
Supply, North Carolina, United States, 28462
- Novant Cancer Institute Radiation Oncology - Supply
-
Wilmington, North Carolina, United States, 28401
- Novant Health New Hanover Regional Medical Center
-
Wilmington, North Carolina, United States, 28401
- Novant Health Cancer Institute Radiation Oncology - Wilmington
-
-
North Dakota
-
Bismarck, North Dakota, United States, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, United States, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, United States, 58122
- Sanford Broadway Medical Center
-
Grand Forks, North Dakota, United States, 58201
- Altru Cancer Center
-
-
Ohio
-
Akron, Ohio, United States, 44307
- Cleveland Clinic Akron General
-
Akron, Ohio, United States, 44304
- Summa Health System - Akron Campus
-
Avon, Ohio, United States, 44011
- UH Seidman Cancer Center at UH Avon Health Center
-
Barberton, Ohio, United States, 44203
- Summa Health System - Barberton Campus
-
Beachwood, Ohio, United States, 44122
- UHHS-Chagrin Highlands Medical Center
-
Canton, Ohio, United States, 44710
- Aultman Health Foundation
-
Chillicothe, Ohio, United States, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, United States, 45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cleveland, Ohio, United States, 44106
- Case Western Reserve University
-
Cleveland, Ohio, United States, 44109
- MetroHealth Medical Center
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, United States, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, United States, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, United States, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, United States, 43228
- Doctors Hospital
-
Columbus, Ohio, United States, 43215
- Grant Medical Center
-
Delaware, Ohio, United States, 43015
- Delaware Health Center-Grady Cancer Center
-
Dublin, Ohio, United States, 43016
- Dublin Methodist Hospital
-
Mansfield, Ohio, United States, 44906
- Cleveland Clinic Cancer Center Mansfield
-
Mansfield, Ohio, United States, 44903
- OhioHealth Mansfield Hospital
-
Marion, Ohio, United States, 43302
- OhioHealth Marion General Hospital
-
Mayfield Heights, Ohio, United States, 44124
- Hillcrest Hospital Cancer Center
-
Medina, Ohio, United States, 44256
- Summa Health Medina Medical Center
-
Mentor, Ohio, United States, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Middleburg Heights, Ohio, United States, 44130
- UH Seidman Cancer Center at Southwest General Hospital
-
Parma, Ohio, United States, 44129
- University Hospitals Parma Medical Center
-
Ravenna, Ohio, United States, 44266
- University Hospitals Portage Medical Center
-
Sandusky, Ohio, United States, 44870
- North Coast Cancer Care
-
Sandusky, Ohio, United States, 44870
- UH Seidman Cancer Center at Firelands Regional Medical Center
-
Strongsville, Ohio, United States, 44136
- Cleveland Clinic Cancer Center Strongsville
-
Sylvania, Ohio, United States, 43560
- ProMedica Flower Hospital
-
Warrensville Heights, Ohio, United States, 44122
- South Pointe Hospital
-
West Chester, Ohio, United States, 45069
- University of Cincinnati Cancer Center-West Chester
-
Wooster, Ohio, United States, 44691
- Cleveland Clinic Wooster Family Health and Surgery Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Health Sciences Center
-
-
Oregon
-
Bend, Oregon, United States, 97701
- Saint Charles Health System
-
Gresham, Oregon, United States, 97030
- Legacy Mount Hood Medical Center
-
Portland, Oregon, United States, 97239
- Oregon Health and Science University
-
Portland, Oregon, United States, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, United States, 97213
- Providence Portland Medical Center
-
Tualatin, Oregon, United States, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18104
- Saint Luke's Cancer Center - Allentown
-
Altoona, Pennsylvania, United States, 16601
- UPMC Altoona
-
Beaver, Pennsylvania, United States, 15009
- UPMC-Heritage Valley Health System Beaver
-
Bethlehem, Pennsylvania, United States, 18015
- Saint Luke's University Hospital-Bethlehem Campus
-
Broomall, Pennsylvania, United States, 19008
- Crozer-Keystone Regional Cancer Center at Broomall
-
Carlisle, Pennsylvania, United States, 17015
- Carlisle Regional Cancer Center
-
Chadds Ford, Pennsylvania, United States, 19317
- Christiana Care Health System-Concord Health Center
-
Chambersburg, Pennsylvania, United States, 17201
- Chambersburg Hospital
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Drexel Hill, Pennsylvania, United States, 19026
- Delaware County Memorial Hospital
-
Dunmore, Pennsylvania, United States, 18512
- Northeast Radiation Oncology Center
-
Easton, Pennsylvania, United States, 18045
- Saint Luke's Hospital-Anderson Campus
-
Ephrata, Pennsylvania, United States, 17522
- Ephrata Cancer Center
-
Erie, Pennsylvania, United States, 16505
- UPMC Hillman Cancer Center Erie
-
Erie, Pennsylvania, United States, 16544
- Saint Vincent Hospital
-
Farrell, Pennsylvania, United States, 16121
- UPMC Cancer Center at UPMC Horizon
-
Gettysburg, Pennsylvania, United States, 17325
- Adams Cancer Center
-
Glen Mills, Pennsylvania, United States, 19342
- Crozer Regional Cancer Center at Brinton Lake
-
Greensburg, Pennsylvania, United States, 15601
- UPMC Cancer Centers - Arnold Palmer Pavilion
-
Harrisburg, Pennsylvania, United States, 17109
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus
-
Hershey, Pennsylvania, United States, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Indiana, Pennsylvania, United States, 15701
- IRMC Cancer Center
-
Jefferson Hills, Pennsylvania, United States, 15025
- Jefferson Hospital
-
Johnstown, Pennsylvania, United States, 15901
- UPMC-Johnstown/John P. Murtha Regional Cancer Center
-
Lebanon, Pennsylvania, United States, 17042
- Sechler Family Cancer Center
-
Lewisburg, Pennsylvania, United States, 17837
- Geisinger Medical Oncology-Lewisburg
-
Meadville, Pennsylvania, United States, 16335
- Yolanda G Barco Oncology Institute
-
Mechanicsburg, Pennsylvania, United States, 17050
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
-
Monroeville, Pennsylvania, United States, 15146
- Forbes Hospital
-
Monroeville, Pennsylvania, United States, 15146
- UPMC Hillman Cancer Center - Monroeville
-
Monroeville, Pennsylvania, United States, 15146
- UPMC Cancer Center - Monroeville
-
Moon Township, Pennsylvania, United States, 15108
- UPMC Hillman Cancer Center in Coraopolis
-
Natrona Heights, Pennsylvania, United States, 15065
- Allegheny Valley Hospital
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, United States, 19114
- Jefferson Torresdale Hospital
-
Philadelphia, Pennsylvania, United States, 19141
- Einstein Medical Center Philadelphia
-
Pittsburgh, Pennsylvania, United States, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, United States, 15224
- West Penn Hospital
-
Pittsburgh, Pennsylvania, United States, 15232
- University of Pittsburgh Cancer Institute (UPCI)
-
Pittsburgh, Pennsylvania, United States, 15232
- UPMC-Shadyside Hospital
-
Pittsburgh, Pennsylvania, United States, 15215
- UPMC-Saint Margaret
-
Pittsburgh, Pennsylvania, United States, 15237
- UPMC-Passavant Hospital
-
Pittsburgh, Pennsylvania, United States, 15243
- UPMC-Saint Clair Hospital Cancer Center
-
Pottsville, Pennsylvania, United States, 17901
- Geisinger Cancer Services-Pottsville
-
Quakertown, Pennsylvania, United States, 18951
- Saint Luke's Hospital-Quakertown Campus
-
Quakertown, Pennsylvania, United States, 18951
- Saint Luke's Hospital - Upper Bucks Campus
-
Seneca, Pennsylvania, United States, 16346
- UPMC Cancer Center at UPMC Northwest
-
Stroudsburg, Pennsylvania, United States, 18360
- Saint Luke's Hospital - Monroe Campus
-
Washington, Pennsylvania, United States, 15301
- UPMC Washington Hospital Radiation Oncology
-
Washington, Pennsylvania, United States, 15301
- UPMC Cancer Center-Washington
-
West Chester, Pennsylvania, United States, 19380
- Chester County Hospital
-
West Reading, Pennsylvania, United States, 19611
- Reading Hospital
-
Wexford, Pennsylvania, United States, 15090
- Wexford Health and Wellness Pavilion
-
Wilkes-Barre, Pennsylvania, United States, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
Williamsport, Pennsylvania, United States, 17754
- Divine Providence Hospital
-
Willow Grove, Pennsylvania, United States, 19090
- Asplundh Cancer Pavilion
-
York, Pennsylvania, United States, 17403
- WellSpan Health-York Cancer Center
-
York, Pennsylvania, United States, 17408
- UPMC Memorial
-
-
South Carolina
-
Bluffton, South Carolina, United States, 29910
- Saint Joseph's/Candler - Bluffton Campus
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
Florence, South Carolina, United States, 29505
- MUSC Health Florence Medical Center
-
Greenville, South Carolina, United States, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, United States, 29601
- Saint Francis Hospital
-
Greenwood, South Carolina, United States, 29646
- Self Regional Healthcare
-
Greer, South Carolina, United States, 29651
- Gibbs Cancer Center-Pelham
-
Hilton Head Island, South Carolina, United States, 29926
- The Radiation Oncology Center-Hilton Head/Bluffton
-
Myrtle Beach, South Carolina, United States, 29577
- Carolina Regional Cancer Center
-
Okatie, South Carolina, United States, 29909
- Beaufort Memorial/New River Cancer Center
-
Spartanburg, South Carolina, United States, 29303
- Spartanburg Medical Center
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, United States, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University/Ingram Cancer Center
-
Nashville, Tennessee, United States, 37203
- The Children's Hospital at TriStar Centennial
-
-
Texas
-
Conroe, Texas, United States, 77384
- MD Anderson in The Woodlands
-
Dallas, Texas, United States, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, United States, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Dallas, Texas, United States, 75237
- UT Southwestern Simmons Cancer Center - RedBird
-
Fort Sam Houston, Texas, United States, 78234
- Brooke Army Medical Center
-
Fort Worth, Texas, United States, 76104
- UT Southwestern/Simmons Cancer Center-Fort Worth
-
Houston, Texas, United States, 77030
- M D Anderson Cancer Center
-
Houston, Texas, United States, 77079
- MD Anderson West Houston
-
League City, Texas, United States, 77573
- MD Anderson League City
-
Richardson, Texas, United States, 75080
- UT Southwestern Clinical Center at Richardson/Plano
-
San Antonio, Texas, United States, 78229
- University of Texas Health Science Center at San Antonio
-
Sugar Land, Texas, United States, 77478
- MD Anderson in Sugar Land
-
-
Utah
-
American Fork, Utah, United States, 84003
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Cedar City, Utah, United States, 84720
- Sandra L Maxwell Cancer Center
-
Farmington, Utah, United States, 84025
- Farmington Health Center
-
Logan, Utah, United States, 84321
- Logan Regional Hospital
-
Murray, Utah, United States, 84107
- Intermountain Medical Center
-
Ogden, Utah, United States, 84403
- McKay-Dee Hospital Center
-
Provo, Utah, United States, 84604
- Utah Valley Regional Medical Center
-
Riverton, Utah, United States, 84065
- Riverton Hospital
-
Salt Lake City, Utah, United States, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, United States, 84143
- LDS Hospital
-
Salt Lake City, Utah, United States, 84106
- University of Utah Sugarhouse Health Center
-
St. George, Utah, United States, 84770
- Saint George Regional Medical Center
-
-
Vermont
-
Berlin Corners, Vermont, United States, 05602
- Central Vermont Medical Center/National Life Cancer Treatment
-
Burlington, Vermont, United States, 05401
- University of Vermont Medical Center
-
Saint Johnsbury, Vermont, United States, 05819
- Dartmouth Cancer Center - North
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia Cancer Center
-
Fairfax, Virginia, United States, 22031
- Inova Schar Cancer Institute
-
Fairfax, Virginia, United States, 22033
- Inova Fair Oaks Hospital
-
Midlothian, Virginia, United States, 23114
- Bon Secours Saint Francis Medical Center
-
Richmond, Virginia, United States, 23230
- Bon Secours Cancer Institute at Reynolds Crossing
-
Richmond, Virginia, United States, 23298
- VCU Massey Comprehensive Cancer Center
-
-
Washington
-
Seattle, Washington, United States, 98101
- Virginia Mason Medical Center
-
Vancouver, Washington, United States, 98686
- Legacy Salmon Creek Hospital
-
Vancouver, Washington, United States, 98684
- Legacy Cancer Institute Medical Oncology and Day Treatment
-
Walla Walla, Washington, United States, 99362
- Providence Saint Mary Regional Cancer Center
-
-
Wisconsin
-
Antigo, Wisconsin, United States, 54409
- Langlade Hospital and Cancer Center
-
Appleton, Wisconsin, United States, 54911
- ThedaCare Regional Cancer Center
-
Appleton, Wisconsin, United States, 54915
- Ascension Saint Elizabeth Hospital
-
Ashland, Wisconsin, United States, 54806
- Northwest Wisconsin Cancer Center
-
Brookfield, Wisconsin, United States, 53045
- Ascension Southeast Wisconsin Hospital - Elmbrook Campus
-
Burlington, Wisconsin, United States, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Chilton, Wisconsin, United States, 53014
- Ascension Calumet Hospital
-
Eau Claire, Wisconsin, United States, 54701
- Marshfield Medical Center-EC Cancer Center
-
Franklin, Wisconsin, United States, 53132
- Ascension Saint Francis - Reiman Cancer Center
-
Germantown, Wisconsin, United States, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, United States, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, United States, 54311
- Aurora BayCare Medical Center
-
Green Bay, Wisconsin, United States, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, United States, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay, Wisconsin, United States, 54301
- Bellin Memorial Hospital
-
Johnson Creek, Wisconsin, United States, 53038
- University of Wisconsin Carbone Cancer Center - Johnson Creek
-
Kenosha, Wisconsin, United States, 53142
- Aurora Cancer Care-Kenosha South
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Madison, Wisconsin, United States, 53718
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
-
Marinette, Wisconsin, United States, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marshfield, Wisconsin, United States, 54449
- Marshfield Medical Center-Marshfield
-
Menomonee Falls, Wisconsin, United States, 53051
- Froedtert Menomonee Falls Hospital
-
Mequon, Wisconsin, United States, 53097
- Ascension Columbia Saint Mary's Hospital Ozaukee
-
Milwaukee, Wisconsin, United States, 53226
- Medical College of Wisconsin
-
Milwaukee, Wisconsin, United States, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, United States, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, United States, 53233
- Aurora Sinai Medical Center
-
Milwaukee, Wisconsin, United States, 53211
- Ascension Columbia Saint Mary's Hospital - Milwaukee
-
Milwaukee, Wisconsin, United States, 53295
- Zablocki Veterans Administration Medical Center
-
Minocqua, Wisconsin, United States, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, United States, 53149
- ProHealth D N Greenwald Center
-
Oak Creek, Wisconsin, United States, 53154
- Drexel Town Square Health Center
-
Oconomowoc, Wisconsin, United States, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oshkosh, Wisconsin, United States, 54904
- Ascension Mercy Hospital
-
Oshkosh, Wisconsin, United States, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Racine, Wisconsin, United States, 53406
- Aurora Cancer Care-Racine
-
Racine, Wisconsin, United States, 53405
- Ascension All Saints Hospital
-
Rhinelander, Wisconsin, United States, 54501
- Aspirus Cancer Care - James Beck Cancer Center
-
Rice Lake, Wisconsin, United States, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, United States, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Sheboygan, Wisconsin, United States, 53081
- Saint Vincent Hospital Cancer Center at Sheboygan
-
Stevens Point, Wisconsin, United States, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Stevens Point, Wisconsin, United States, 54481
- Aspirus Cancer Care - Stevens Point
-
Sturgeon Bay, Wisconsin, United States, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Summit, Wisconsin, United States, 53066
- Aurora Medical Center in Summit
-
Two Rivers, Wisconsin, United States, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Waukesha, Wisconsin, United States, 53188
- UW Cancer Center at ProHealth Care
-
Wausau, Wisconsin, United States, 54401
- Aspirus Regional Cancer Center
-
Wauwatosa, Wisconsin, United States, 53226
- Aurora Cancer Care-Milwaukee West
-
Wauwatosa, Wisconsin, United States, 53226
- Ascension Medical Group Southeast Wisconsin - Mayfair Road
-
West Allis, Wisconsin, United States, 53227
- Aurora West Allis Medical Center
-
West Bend, Wisconsin, United States, 53095
- Froedtert West Bend Hospital/Kraemer Cancer Center
-
Weston, Wisconsin, United States, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, United States, 54494
- Aspirus Cancer Care - Wisconsin Rapids
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pathologically (histologically or cytologically) proven diagnosis of adenocarcinoma of the prostate within 270 days prior to registration
Unfavorable intermediate risk prostate cancer, defined as having ALL the following bulleted criteria:
Has at least one intermediate risk factor (IRF):
- PSA 10-20 ng/mL
- Clinical stage T2b-c (digital rectal examination [DRE] and/or imaging) by American Joint Committee on Cancer (AJCC) 8th edition
- Gleason score 7 (Gleason 3+4 or 4+3 [ International Society of Urological Pathology (ISUP) Grade Group 2-3])
Has ONE or more of the following 'unfavorable' intermediate-risk designators:
- > 1 immature reticulocyte fraction (IRF)
- Gleason 4+3=7 (ISUP Grade Group 3)
>= 50% of biopsy cores positive
- Biopsies may include 'sextant' sampling of right/left regions of the prostate, often labeled base, mid-gland and apex. All such 'sextant' biopsy cores should be counted. Men may also undergo 'targeted' sampling of prostate lesions (guided by MRI, ultrasound or other approaches). A targeted lesion that is biopsied more than once and demonstrates cancer (regardless of number of targeted cores involved) should count as a single additional positive core sampled and positive. In cases of uncertainty, count the biopsy sampling as sextant core(s)
- Absence of high-risk features
Appropriate stage for study entry based on the following diagnostic workup:
- History/physical examination within 120 days prior to registration;
- Negative bone imaging (M0) within 120 days prior to registration; Note: Tc-99m bone scan or sodium fluoride (NaF) positron emission tomography (PET) are allowed. Equivocal bone scan findings are allowed if plain films X-ray, computed tomography (CT) or magnetic resonance imaging (MRI) are negative for metastasis at the concerned site(s). While a negative fluciclovine, choline, or prostate specific membrane antigen (PSMA) PET may be counted as acceptable substitute for bone imaging, any suspicious findings must be confirmed and correlated with conventional imaging (Tc-99m bone scan, NaF PET, CT, X-ray, or MRI) to determine eligibility based on the latter modalities (e.g. M0 based on conventional imaging modalities)
- Clinically negative lymph nodes (N0) as established by conventional imaging (pelvic +/- abdominal CT or MR), within 120 days prior to registration. Patients with lymph nodes equivocal or questionable by imaging are eligible if the nodes are =< 1.0 cm in short axis and/or if biopsy is negative.
Note: While a negative fluciclovine, choline, or prostate specific membrane antigen (PSMA) PET may be counted as acceptable substitute for pelvic imaging, any suspicious findings must be confirmed by conventional imaging (CT, MRI or biopsy). If the findings do not meet pathological criteria based on the latter modalities (e.g. node =< 10 mm in short axis, negative biopsy), the patient will still be eligible
- Age >= 18
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 within 120 days prior to registration
- Non-castrate testosterone level (> 50 ng/dL) within 120 days prior to registration
- Absolute neutrophil >= 1,000 cells/mm^3 (within 120 days prior to registration)
- Hemoglobin >= 8.0 g/dL, independent of transfusion and/or growth factors (within 120 days prior to registration)
- Platelet count >= 100,000 cells/mm^3 independent of transfusion and/or growth factors (within 120 days prior to registration)
Creatinine clearance (CrCl) >= 30 mL/min estimated by Cockcroft-Gault equation (within 120 days prior to registration)
- For African American patients specifically whose renal function is not considered adequate by the formula above, an alternative formula that takes race into account (Chronic Kidney Disease Epidemiology Collaboration CKD-EPI formula) should be used for calculating the related estimated glomerular filtration rate (GFR) with a correction factor for African American race creatinine clearance for trial eligibility, where GFR >= 30 mL/min/1.73m^2 will be considered adequate
- Total bilirubin: 1.5 =< institutional upper limit of normal (ULN) (within 120 days prior to registration) (Note: In subjects with Gilbert's syndrome, if total bilirubin is > 1.5 x ULN, measure direct and indirect bilirubin. If direct bilirubin is less than or equal to 1.5 x ULN, subject is eligible)
- Aspartate aminotransferase (AST)(serum glutamic-oxaloacetic transaminase [SGOT]) and alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase [SGPT]): =< 2.5 x institutional ULN (within 120 days prior to registration)
- Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial; Note: HIV testing is not required for eligibility for this protocol
For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.
- Note: Known positive test for hepatitis B virus surface antigen (HBV sAg) indicating acute or chronic infection would make the patient ineligible unless the viral load becomes undetectable on suppressive therapy. Patients who are immune to hepatitis B (anti-Hepatitis B surface antibody positive) are eligible (e.g. patients immunized against hepatitis B)
For patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load
- Note: Known positive test for hepatitis C virus ribonucleic acid (HCV RNA) indicating acute or chronic infection would make the patient ineligible unless the viral load becomes undetectable on suppressive therapy
- The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information
Exclusion Criteria:
- Previous radical surgery (prostatectomy) or any form of curative-intent ablation whether focal or whole-gland (e.g., cryosurgery, high intensity focused ultrasound [HIFU], laser thermal ablation, etc.) for prostate cancer
- Definitive clinical or radiologic evidence of metastatic disease (M1)
- Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years. History of or current diagnosis of hematologic malignancy is not allowed
- Prior radiotherapy to the prostate/pelvis region that would result in overlap of radiation therapy fields
- Previous bilateral orchiectomy
- Previous hormonal therapy, such as luteinizing hormone-releasing hormone (LHRH) agonists (e.g., leuprolide, goserelin, buserelin, triptorelin) or LHRH antagonist (e.g. degarelix), anti-androgens (e.g., flutamide, bicalutamide, cyproterone acetate). ADT started prior to study registration is not allowed
- Prior use of 5-alpha-reductase inhibitors is allowed, however, it must be stopped prior to enrollment on the study with at least a 30 day washout period before baseline study PSA measure and registration
- Active testosterone replacement therapy; any replacement therapy must be stopped at least 30 days prior to registration
Severe, active co-morbidity defined as follows:
- Current severe or unstable angina;
- New York Heart Association Functional Classification III/IV (Note: Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification)
- History of any condition that in the opinion of the investigator, would preclude participation in this study
- Inability to swallow oral pills
High risk features, which includes any of the following:
- Gleason 8-10 [ISUP Grade Group 4-5]
- PSA > 20
- cT3-4 by digital exam OR gross extra-prostatic extension on imaging [indeterminate MRI evidence will not count and the patient will be eligible]
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm III (RT, ADT)
Patients receive treatment as in Arm II.
|
Undergo RT
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
|
|
Experimental: Arm IV (RT, ADT, darolutamide)
Patients receive RT and ADT as in Arm II.
Patients also receive darolutamide PO BID on days 1-90.
Treatment repeats every 90 days for up to 2 cycles in the absence of disease progression or unacceptable toxicity.
|
Undergo RT
Other Names:
Given PO
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
|
|
Experimental: Arm I (RT)
Patients undergo radiation therapy (RT) using a recognized regimen (2-3 days a week or 5 days a week for 2-11 weeks) in the absence of disease progression or unacceptable toxicity.
|
Undergo RT
Other Names:
|
|
Experimental: Arm II (RT, ADT)
Patients undergo RT as Arm I. Patients also receive androgen deprivation therapy (ADT) consisting of leuprolide, goserelin, buserelin, histrelin, triptorelin, degarelix, or relugolix at the discretion of the treating physician, for 6 months in the absence of disease progression or unacceptable toxicity.
Patients may also receive bicalutamide or flutamide for 0, 30 or 180 days.
|
Undergo RT
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
Drug
Drug
Other Names:
Drug
Other Names:
Drug
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distant metastasis (DM) (De-intensification study)
Time Frame: From randomization to the detection of distant metastasis by conventional imaging, assessed up to 5 years
|
From randomization to the detection of distant metastasis by conventional imaging, assessed up to 5 years
|
|
|
Metastasis-free survival (MFS) (Intensification study)
Time Frame: From randomization until the occurrence of distant metastasis by conventional imaging or death from any cause, assessed up to 5 years
|
MFS will be estimated by the Kaplan-Meier (1958) method and compared between the two treatment arms using a stratified log-rank test (stratified by the randomization stratification factors) at one-sided alpha level of 0.025.
|
From randomization until the occurrence of distant metastasis by conventional imaging or death from any cause, assessed up to 5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sexual and hormonal function related quality of life
Time Frame: Up to 5 years
|
Measured by the Expanded Prostate Cancer Index Composite-26 (EPIC-26).
|
Up to 5 years
|
|
Fatigue
Time Frame: Up to 5 years
|
Measured by the Patient Reported Outcomes Measurement Information System (PROMIS)-Fatigue instrument.
|
Up to 5 years
|
|
Cognition
Time Frame: Up to 5 years
|
Measured by the Functional Assessment of Chronic illness Therapy-Cognitive (FACT-Cog).
|
Up to 5 years
|
|
Overall survival
Time Frame: From randomization to death from any cause, assessed up to 5 years
|
Will be estimated by the Kaplan-Meier method and compared between treatments arms by stratified log-rank test.
Cox regression models will also be fit, adjusted for the stratification factors, to estimate hazard ratios, together with 95% confidence intervals.
|
From randomization to death from any cause, assessed up to 5 years
|
|
Time to prostate specific antigen (PSA) failure
Time Frame: Up to 5 years
|
Defined as PSA > 2 ng/ml above the nadir post randomization.
Will be analyzed using competing-risk methods (Gooley 1999) where, in each case, death prior to occurrence of the event in question will be a competing risk.
|
Up to 5 years
|
|
MFS (De-intensification study)
Time Frame: From randomization until the occurrence of distant metastasis by conventional imaging or death from any cause, assessed up to 5 years
|
Will be estimated by the Kaplan-Meier method and compared between treatments arms by stratified log-rank test.
Cox regression models will also be fit, adjusted for the stratification factors, to estimate hazard ratios, together with 95% confidence intervals.
|
From randomization until the occurrence of distant metastasis by conventional imaging or death from any cause, assessed up to 5 years
|
|
MFS including positron emission tomography (PET) imaging
Time Frame: From randomization until the occurrence of distant metastasis by conventional and/or molecular imaging or death from any cause, assessed up to 5 years
|
Will be estimated by the Kaplan-Meier method and compared between treatments arms by stratified log-rank test.
|
From randomization until the occurrence of distant metastasis by conventional and/or molecular imaging or death from any cause, assessed up to 5 years
|
|
Locoregional failure (LRF)
Time Frame: From randomization until local or regional recurrence based upon conventional imaging or biopsy, assessed up to 5 years
|
Will compare cumulative incidence between arms.
|
From randomization until local or regional recurrence based upon conventional imaging or biopsy, assessed up to 5 years
|
|
DM including PET imaging
Time Frame: From randomization to the detection of distant metastasis by conventional and/or molecular imaging, assessed up to 5 years
|
Will be analyzed using competing-risk methods (Gooley 1999) where, in each case, death prior to occurrence of the event in question will be a competing risk.
|
From randomization to the detection of distant metastasis by conventional and/or molecular imaging, assessed up to 5 years
|
|
Prostate cancer-specific mortality
Time Frame: From randomization until death from prostate cancer, assessed up to 5 years
|
Will be analyzed using competing-risk methods (Gooley 1999) where, in each case death from causes other than prostate cancer as the competing risk.
|
From randomization until death from prostate cancer, assessed up to 5 years
|
|
DM (Intensification study)
Time Frame: From randomization to the detection of distant metastasis by conventional imaging, assessed up to 5 years
|
Will be analyzed using competing-risk methods (Gooley 1999) where, in each case, death prior to occurrence of the event in question will be a competing risk.
|
From randomization to the detection of distant metastasis by conventional imaging, assessed up to 5 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bowel and urinary function related quality of life
Time Frame: Up to 5 years
|
Measured EPIC-26.
Mixed effect regression models will be fit to compare the changes over time in the domain scores.
Covariates will include treatment, time, and treatment-by-time treatment interaction terms.
|
Up to 5 years
|
|
Cardio-metabolic markers
Time Frame: Up to 5 years
|
Will include body mass index, lipids, blood glucose, complete blood count, comprehensive metabolic panel, and hemoglobin A1c.
Mixed effect regression models will be fit to compare the changes over time in the cardio-metabolic markers between treatment groups.
Covariates will include treatment, time, and treatment-by-time treatment interaction terms.
|
Up to 5 years
|
|
Health utilities
Time Frame: Up to 5 years
|
Measured by the European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L).
).
The bootstrap (Efron 1980) will be performed to obtain standard errors, test for significant differences, and generate 95% confidence intervals.
|
Up to 5 years
|
|
Castrate-resistant prostate cancer (CRPC)
Time Frame: Up to 5 years
|
CRPC is defined as PSA increase > 25% and more than 2 ng/mL above nadir on study in conjunction with a serum testosterone (T) < 50 ng/mL, confirmed by repeat measurements at least 2 weeks apart.
Will be analyzed using competing-risk methods (Gooley 1999) where, in each case, death prior to occurrence of the event in question will be a competing risk.
|
Up to 5 years
|
|
PSA failure-free survival with non-castrate testosterone and no additional therapies
Time Frame: Up to 5 years
|
Up to 5 years
|
|
|
Locoregional failure based upon either conventional or molecular imaging
Time Frame: Up to 5 years
|
Up to 5 years
|
|
|
Time to testosterone recovery
Time Frame: From randomization until T > 200 ng/dL, assessed up to 5 years
|
Will be analyzed using competing-risk methods (Gooley 1999) where, in each case, death prior to occurrence of the event in question will be a competing risk.
Changes in quality of life measures will be correlated with changes in testosterone levels.
|
From randomization until T > 200 ng/dL, assessed up to 5 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Neil B Desai, NRG Oncology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms
- Neoplasms by Histologic Type
- Neoplasms, Glandular and Epithelial
- Carcinoma
- Adenocarcinoma
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Pituitary Hormone-Releasing Hormones
- Hypothalamic Hormones
- Peptide Hormones
- Neuropeptides
- Peptides
- Amino Acids, Peptides, and Proteins
- Oligopeptides
- Nerve Tissue Proteins
- Proteins
- Organic Chemicals
- Therapeutics
- Hydrocarbons
- Hydrocarbons, Cyclic
- Physical Phenomena
- Carboxylic Acids
- Hydroxy Acids
- Hydrocarbons, Aromatic
- Anilides
- Amides
- Aniline Compounds
- Amines
- Phenols
- Benzene Derivatives
- Acids, Carbocyclic
- Benzoates
- Salicylates
- Hydroxybenzoates
- Gonadotropin-Releasing Hormone
- Salicylic Acid
- Leuprolide
- Goserelin
- Triptorelin Pamoate
- Flutamide
- Buserelin
- acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
- relugolix
- darolutamide
- Radiotherapy
- Radiation
- bicalutamide
- histrelin
Other Study ID Numbers
- NRG-GU010 (Other Identifier: CTEP)
- U10CA180868 (U.S. NIH Grant/Contract)
- NCI-2021-08760 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Adenocarcinoma
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsRecruitingRecurrent Prostate Adenocarcinoma | Oligometastatic Prostate AdenocarcinomaUnited States
-
Case Comprehensive Cancer CenterTerminatedAdenocarcinoma of Prostate | Adenocarcinoma of the Prostate Stage I | Adenocarcinoma of the Prostate Stage II | Adenocarcinoma of the Prostate Stage IIIUnited States
-
Srinivas RamanNot yet recruitingProstate Adenocarcinoma
-
Royal Surrey County Hospital NHS Foundation TrustNot yet recruitingProstate AdenocarcinomaUnited Kingdom
-
IRCCS San RaffaeleCompleted
-
National Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Adenocarcinoma AJCC v7 | Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Prostate Adenocarcinoma With Neuroendocrine...United States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the Prostate Stage I | Adenocarcinoma of the Prostate Stage II | Adenocarcinoma of the Prostate Stage IIIUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in Lymph Node | Prostate Ductal Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
University of California, San FranciscoCompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage I Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7United States
Clinical Trials on Radiation Therapy
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Puerto Rico, Switzerland, New Zealand
-
University of California, San FranciscoVarian Medical SystemsRecruitingStage IV Anal Cancer AJCC v8 | Metastatic Gastroesophageal Junction Adenocarcinoma | Metastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Postneoadjuvant Therapy Stage... and other conditionsUnited States
-
Medical College of WisconsinCompletedResectable Head and Neck Squamous Cell CarcinomaUnited States
-
Medical College of WisconsinActive, not recruitingHead and Neck CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Changhai HospitalRecruitingLocalized Prostate CancerChina
-
NYU Langone HealthCompletedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnn Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Extranodal Marginal Zone LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingPatients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to RadiationCanada